Living biotherapeutic product - Ginkgo Bioworks/Tantu Therapeutics
Latest Information Update: 28 Oct 2025
At a glance
- Originator Tantu Therapeutics
- Class Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gastrointestinal disorders; Inflammatory bowel diseases
Most Recent Events
- 28 Oct 2025 No recent reports of development identified for research development in Gastrointestinal-disorders in USA (PO)
- 28 Oct 2025 No recent reports of development identified for research development in Inflammatory-bowel-diseases in USA (PO)
- 07 Sep 2021 Early research in Gastrointestinal disorders in USA (PO)